Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial

Author:

Somaiah Neeta,Conley Anthony P,Parra Edwin Roger,Lin Heather,Amini Behrang,Solis Soto Luisa,Salazar Ruth,Barreto Carmelia,Chen Honglei,Gite Swati,Haymaker Cara,Nassif Elise F,Bernatchez Chantale,Mitra Akash,Livingston John Andrew,Ravi Vinod,Araujo Dejka M,Benjamin Robert,Patel Shreyaskumar,Zarzour Maria A,Sabir Sharjeel,Lazar Alexander J,Wang Wei-Lien,Daw Najat C,Zhou Xiao,Roland Christina L,Cooper Zachary A,Rodriguez-Canales Jaime,Futreal Andrew,Soria Jean-Charles,Wistuba Ignacio I,Hwu Patrick

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Clinical features and outcomes of primary bone and soft tissue sarcomas in adolescents and young adults;Hashimoto;Mol Clin Oncol,2020

2. Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: a phase III NRG Oncology/Gynecologic Oncology group study;Hensley;J Clin Oncol,2018

3. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial;an der Graaf;Lancet,2012

4. Efficacy of trabectedin for the treatment of liposarcoma;Zijoo;Expert Opin Pharmacother,2016

5. Eribulin in advanced liposarcoma and leiomyosarcoma;Setola;Expert Rev Anticancer Ther,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3